|
Volumn 154, Issue 12, 1997, Pages 1792-1794
|
Schizophrenia practice guideline [3] (multiple letters)
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
PROLACTIN;
RISPERIDONE;
DEPRESSION;
ECONOMIC ASPECT;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HYPERPROLACTINEMIA;
HYPOGONADISM;
INFERTILITY;
LETTER;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PSYCHOSOCIAL CARE;
REINFORCEMENT;
SCHIZOPHRENIA;
SOCIAL LEARNING;
TARDIVE DYSKINESIA;
NOTE;
STANDARD;
BEHAVIOR THERAPY;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
ANTIPSYCHOTIC AGENTS;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
SCHIZOPHRENIA;
BEHAVIOR THERAPY;
COMBINED MODALITY THERAPY;
TOKEN ECONOMY;
|
EID: 0030657630
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (0)
|